Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Johnson & Johnson research unit says the decision is strategic, citing a crowded HCV treatment market.
Jim O’Neill is also interested in immortality. For real.
Most new treatments are in early Phase I or Phase II clinical trials. Study results are expected as soon as 2015.
Pharmasset has announced plans to amend one of its Phase II clinical trials in the wake of liver toxicity concerns among some volunteers
The National Institutes of Health is forming a new center whose purpose will be to develop new medications
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.